Patient selection for prostate multiparametric MRI (mpMRI) has been made easy by a newly developed machine learning model.
With mpMRI increasingly used for prostate cancer detection, this machine learning model can aid in patient selection to optimize resource utilization and reduce unnecessary costs, according to Zachary Nuffer of the University of Rochester Medical Center, who will present his findings at the ARRS 2018 Annual Meeting.
Decipher Test for Prostate Cancer
Decipher test a genomic test for prostate cancer that determines the aggressiveness of the cancer and helps in planning the treatment course for the cancer.
Advertisement
‘According to this study, a newly developed machine learning model developed by Microsoft Azure Machine Learning can accurately predict which patients are most likely to benefit from prostate multiparametric MRI (mpMRI).’
Tweet it Now
A total of 811 prostate mpMRI examinations from four tertiary care centers with mpMRI expertise were used to develop a support vector machine model for predicting PI-RADS category 4 or 5 lesions on the basis of patient age, prostate specific antigen, and prostate volume. Patients either had no prior prostate biopsy or had a negative prior prostate biopsy. The model was developed on the Microsoft Azure Machine Learning platform and can be accessed at birch.azurewebsites.net. The model was then tested prospectively on 42 patients.
The model showed 73 percent accuracy for predicting PI-RADS category 4 or 5 lesions on the basis of 10-fold cross validation. Prospective validation of the model demonstrates a sensitivity of 75 percent and specificity of 82 percent for a cutoff threshold of 43 percent for predicting PI-RADS category 4 or 5 lesions.
With educational activities representing the entire spectrum of radiology, ARRS will host leading radiologists from around the world at the ARRS 2018 Annual Meeting, April 22-27, at the Marriott Wardman Park Hotel in Washington, DC.
Source: Eurekalert
With educational activities representing the entire spectrum of radiology, ARRS will host leading radiologists from around the world at the ARRS 2018 Annual Meeting, April 22-27, at the Marriott Wardman Park Hotel in Washington, DC.
Source: Eurekalert
Brachytherapy for Prostate Cancer
Learn about two different types of brachytherapy used for treating prostate cancer. Get information on the latest advances in the field.
Advertisement
 Drugs for Prostate CancerProstate cancer is the main cause of cancer death in men. One of the treatment method includes prescribing chemotherapeutic or hormonal drugs. These are prescribed depending on the type and stage of cancer. | Advertisement
|
Medical Management of Prostate Cancer
Prostate cancer is the second most common cancer in men after skin cancer and it is the sixth leading cause of death in men worldwide.
Advertisement
Recommended Readings
![Prostate Specific Antigen [PSA]](https://www.medindia.net/images/patientinfo/120x100/prostate-specific-antigen.jpg "Prostate Specific Antigen [PSA]")
Latest Research News
Researchers establish connections between Alzheimer's-linked genetic alterations and the functioning of brain cells.
Team at NeuroRestore introduces a groundbreaking gene therapy that has effectively promoted nerve regrowth and reconnection, post spinal cord injury.
Scientists aim to pinpoint particular functional pathways affected by these bacteria that may have an impact on skeletal health.
Consuming a diet rich in saturated fats triggers persistent, low-level inflammation within the body, ultimately contributing to the onset of metabolic syndrome.
Ae. aegypti mosquitoes are carriers of "arthropod-borne" or "arbo-" viruses, which encompass the dengue virus, yellow fever virus, Zika virus, and chikungunya virus.
